跳至主要内容
临床试验/JPRN-UMIN000002401
JPRN-UMIN000002401已完成未知

A randomized controlled trial of sorafenib versus 5-FU arterial infusion and interferon therapy (FAIT) for advanced hepatocellular carcinoma - A randomized controlled trial of sorafenib versus 5-FU arterial infusion and interferon therapy (FAIT) for advanced hepatocellular carcinoma

Department of Hepatology, Kyoundo Hospital0 个研究点目标入组 140 人开始时间: 2009年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • See inclusion criteria.

研究者

发起方
Department of Hepatology, Kyoundo Hospital

相似试验

招募中
3 期
Randomized phase III trial of Sorafenib versus Lenvatinib as a second-line treatment after immune check point inhibitor for advanced hepatocellular carcinomaHepatocellular carcinoma
JPRN-jRCT1031210167eno Makoto164
进行中(未招募)
1 期
A randomized phase II trial assessing Sorafenib (Nexavar®) in combination with irinotecan in metastatic colorectal cancer patients with KRAS mutated tumours after failure of all active drugs known to be effective. - NEXIRI 2metastatic colorectal cancerMedDRA version: 16.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864
EUCTR2012-000644-94-FRCentre Val d’Aurelle - Paul Lamarque159
进行中(未招募)
1 期
An exploratory study of sorafenib for patients listed for transplantation due to HCCPatients >18 years with hepatocellular carcinoma, on waiting list for liver transplantationMedDRA version: 12.1Level: LLTClassification code 10019829Term: Hepatocellular carcinoma recurrentMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectable
EUCTR2010-024306-36-SEVästra Götalandsregionen21
撤回
2 期
Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid CarcinomaMedullary Thyroid Carcinoma
NCT01736878Eanm Research Ltd
招募中
不适用
Evaluation of the safety and efficacy of sorafenib therapy after TACE for unresectable hepatocellular carcinoma (multicenter study)Hepatocellular carcinoma
JPRN-UMIN000006475Kagoshima University Medical and Dental Hospital70